Transcription factor Egr-1 activates collagen expression in immortalized fibroblasts or fibrosarcoma cells
(1) Alternative Pathway Device Pass-Through Applications As discussed in the CY 2026 OPPS/ASC proposed rule, we received four device pass-through applications by the March 2025 quarterly application deadline for devices that have received Breakthrough Device designation from FDA and FDA marketing authorization for the indication for which they have a Breakthrough Device designation and, therefore were eligible to apply under the alternative pathway
Choline: a nutrient thats key for liver function, helping to remove toxins and prevent fat from accumulating in the liver
Each batch is verified for purity and identity, giving laboratories a documented reference point before integrating AOD 9604 peptide into active research workflows
On the opposing side, PhRMA, the Partnership for Safe Medicines, and the American Pharmacists Association each filed against inclusion of all seven substances, with the Partnership for Safe Medicines specifically flagging reports of Chinese manufacturers who previously produced fentanyl precursors now pivoting into peptide sales
Therefore, we are excited to add peptide therapy to our immune and autoimmune protocols
